A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Mascarenhas, M.D.
Mt. Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ap-Hp Hopital Saint-Louis
Paris, France
Recruiting
- Irccs Azienda Ospedaliero-Universitaria Di Bologna - Policlinico Di Sant Orsola
Bologna, Italy, Italy
Not, yet, recruiting - Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, Italy
Not, yet, recruiting
- Hospital General Universitario Gregorio Maranon
Madrid, Spain, Spain
Recruiting - Hospital Clinic Barcelona
Barcelona, Spain
Recruiting - Hospital Universitario Ramon Y Cajal
Madrid, Spain
Recruiting
- Guy'S Hospital
London, UK, United Kingdom
Not, yet, recruiting - Genesis Cancer Care Uk Limited - Oxford
Oxford, UK, United Kingdom
Not, yet, recruiting
- Stanford Cancer Institute
Palo Alto, California, United States
Recruiting - Moffitt Cancer Cancer Center
Tampa, Florida, United States
Recruiting - University of Kansas Medical Center
Kansas City, Kansas, United States
Recruiting - Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Massachusetts General Hospital
Boston, Massachusetts, United States
Recruiting - University of Michigan
Ann Arbor, Michigan, United States
Recruiting - Washington University School of Medicine
St Louis, Missouri, United States
Recruiting - David H. Koch Center for Cancer Care at Memorial Sloan Kettering
New York, New York, United States
Recruiting - Icahn School of Medicine at Mount Sinai
New York, New York, United States
Recruiting - Levine Cancer Institute
Charlotte, North Carolina, United States
Recruiting - University of Cincinnati
Cincinnati, Ohio, United States
Recruiting - the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2024
- Primary completion
- 15 Oct 2026
- Completion
- 15 Feb 2027
- Last update posted
- 12 May 2026
- Registered enrollment
- 76
- Registry id
- NCT06343805
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.